Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(23), P. 7453 - 7453
Published: Dec. 7, 2024
We
aimed
to
compare
the
prescribing
behavior
and
clinical
experience
of
urology
providers
when
using
combined
multiplex
polymerase
chain
reaction
(M-PCR)/Pooled
Antibiotic
Susceptibility
Testing
(P-AST)
diagnostic
test
versus
standard
urine
culture
(SUC)
in
same
set
patients
previously
reported
have
improved
outcomes
with
M-PCR/P-AST.
BMC Infectious Diseases,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Jan. 31, 2024
Abstract
Background
Current
diagnoses
of
urinary
tract
infection
(UTI)
by
standard
urine
culture
(SUC)
has
significant
limitations
in
sensitivity,
especially
for
fastidious
organisms,
and
the
ability
to
identify
organisms
polymicrobial
infections.
The
rate
both
SUC
“negative”
or
“mixed
flora/contamination”
results
UTI
cases
high
prevalence
asymptomatic
bacteriuria
indicate
need
an
accurate
diagnostic
test
help
true
cases.
This
study
aimed
determine
if
infection-associated
biomarkers
can
differentiate
definitive
from
non-UTI
controls.
Methods
Midstream
clean-catch
voided
samples
were
collected
volunteers
symptomatic
subjects
≥
60
years
old
diagnosed
with
a
urology
specialty
setting.
Microbial
identification
density
assessed
using
multiplex
PCR/pooled
antibiotic
susceptibility
(M-PCR/P-AST)
SUC.
Three
[neutrophil
gelatinase-associated
lipocalin
(NGAL),
Interleukins
8
1β
(IL-8,
IL-1β)]
also
measured
via
enzyme-linked
immunosorbent
assay
(ELISA).
Definitive
defined
as
diagnosis
positive
microorganism
detection
M-PCR,
while
volunteers.
Results
We
observed
strong
correlation
(R
2
>
0.90;
p
<
0.0001)
between
microbial
NGAL,
IL-8,
IL-1β
subjects.
Biomarker
consensus
criteria
two
more
had
sensitivity
84.0%,
specificity
91.2%,
predictive
value
93.7%,
negative
78.8%,
accuracy
86.9%,
likelihood
ratio
9.58,
0.17
differentiating
cases,
regardless
non-zero
density.
showed
elevation
microbe
compared
without
identification.
exhibited
distinguishing
Conclusion
demonstrated
that
IL-1β,
and/or
M-PCR
was
associated
A
criterion
meeting
positivity
thresholds
good
balance
(84.0%),
(91.2%),
(86.9%).
Therefore,
this
biomarker
is
excellent
supportive
tool
resolving
presence
active
UTI,
particularly
disagree.
Antibiotics,
Journal Year:
2025,
Volume and Issue:
14(2), P. 143 - 143
Published: Feb. 1, 2025
Background/Objectives:
Urinary
tract
infections
(UTIs)
pose
an
increasing
risk
of
antimicrobial
resistance,
and
novel
diagnostic
tests
have
been
developed
to
address
the
limitations
standard
urine
culture
in
these
cases.
It
is
important
that
be
validated
for
agreement
error
rates
against
antibiotic
susceptibility
testing
(AST)
methods.
Methods:
Polymicrobial
(≥two
non-fastidious
microorganisms)
consecutive
clinical
specimens
submitted
UTI
were
included
this
analysis.
Specimens
tested
with
Pooled
Antibiotic
Susceptibility
Testing
(P-AST)
broth
microdilution/disk
diffusion
(BMD/DD)
parallel.
Performance
characteristics,
such
as
essential
(EA%),
very
major
errors
(VMEs),
(MEs),
assessed
using
Clinical
Laboratory
Standards
Institute
(CLSI)
standards.
P-AST-resistant
BMD/DD
consensus-sensitive
results
heteroresistance.
Real-world
sample
data
used
assess
associations
between
organism
counts
average
“sensitive”
count
per
sample.
Results:
The
P-AST
isolate
AST
was
≥90%,
VMEs
<2.0%,
MEs
<3.0%,
meeting
CLSI
guidelines
verification
validation
studies.
When
heteroresistance
accounted
for,
overall
both
<1.5%.
presence
additional
organisms
dropped
number
antibiotics
from
9.8
one
2.5
five
or
more
organisms.
fastidious
did
not
any
meaningful
impact.
Conclusions:
P-AST,
a
component
Guidance®
assay
(Pathnostics,
Irvine,
CA,
USA),
performed
within
standards
polymicrobial
specimens.
Microorganisms,
Journal Year:
2025,
Volume and Issue:
13(4), P. 949 - 949
Published: April 20, 2025
Clinical
success
in
treating
complicated
urinary
tract
infections
(cUTIs)
depends
on
accurate
pathogen
detection,
given
the
common
occurrence
of
polymicrobial
and
antimicrobial
resistance.
This
multicenter,
randomized,
investigator-blinded
study
compared
polymerase
chain
reaction
(PCR)-based
diagnostics
to
conventional
culture
sensitivity
(C&S)
testing
guiding
treatment
cUTIs.
PCR
identified
43.52%
cases,
a
significantly
higher
rate
than
that
observed
with
C&S
(31.95%,
p
=
0.033).
Patients
arms
undetected
had
clinical
failure
(33.33%,
14/42,
0.041)
those
concordant
infection
identification
by
both
methods
(22.22%,
12/54).
also
detected
additional
pathogens
54.44%
(92/169)
cases
arm,
where
was
when
missed
(28.26%
vs.
14.29%,
0.015).
Similarly,
failed
detect
phenotypic
resistance
(compared
PCR),
occurred
50%
(16/42)
13.22%
(21/121,
0.001)
detection
(PCR
C&S).
To
further
illustrate
impact,
patient-level
case
analyses
are
included
demonstrate
how
PCR-guided
therapy
improved
enabled
more
appropriate
selection
C&S.
These
findings
highlight
limitations
detecting
infections,
resistance,
hetero-resistance
due
its
limited
clonal
analysis,
supporting
integration
for
optimized
cUTI
management.
Investigative and Clinical Urology,
Journal Year:
2025,
Volume and Issue:
66(3), P. 261 - 261
Published: Jan. 1, 2025
We
aimed
to
evaluate
the
effect
of
long-term
oral
OM-89
therapy
on
urinary
microflora
in
patients
with
urolithiasis.
Patients
underwent
surgical
removal
stones
followed
by
no
treatment
for
six
months
or
daily
administration.
Urine
culture
and
polymerase
chain
reaction
(PCR)
were
performed
at
baseline
visit
(V1)
2
(V2)
6
(V3)
after
operation.
A
total
113
completed
study.
The
rate
bacteria
detection
urine
V3
did
not
differ
between
treated
untreated
groups
(p>0.999);
however,
PCR
tended
be
higher
group
than
(p=0.052).
Escherichia
coli
Enterococcus
spp.
most
commonly
detected
via
both
all
timepoints.
Risk
factors
positive
V1
(p=0.048)
female
sex
(p=0.048),
whereas
was
associated
(p=0.023),
V2
(p<0.001),
(p=0.038).
use
decreased
rates
bacterial
a
further
decrease
V3.
Long-term
immunization
could
frequency
colonization
stones.
used
as
complementary
if
retrieved
stone
is
suspected
related
infection.
Frontiers in Pediatrics,
Journal Year:
2024,
Volume and Issue:
12
Published: May 22, 2024
Introduction
Early
and
accurate
diagnosis
of
urinary
tract
infection
(UTI)
can
prevent
serious
sequelae
including
chronic
kidney
disease.
Multiple
individual
studies
have
identified
urine
neutrophil
gelatinase-associated
lipocalin
(uNGAL)
as
a
promising
biomarker
for
early
UTI.
We
sought
to
understand
the
distribution
diagnostic
accuracy
uNGAL
values
in
patients
presenting
with
UTI
symptoms.
Methods
Our
systematic
literature
reviews
PubMed,
Embase,
Cochrane
Reviews
up
March
2024,
25
reporting
mean/median,
standard
deviation/quartiles,
detection
limits
symptomatic
without
culture-confirmed
Seventeen
were
children.
Meta-analyses
performed
using
quantile
estimation
(QE)
method
estimating
distributions
uNGAL,
which
then
compared
between
non-UTI
groups
identifying
best
cut-off
points
maximizing
Youden
index.
Sensitivity
analyses
on
all
adult
patients.
Results
found
that
levels
significantly
higher
samples
confirmed
those
without.
In
pediatric
studies,
median
95%
confidence
interval
(CI)
22.41
(95%
CI
9.94,
50.54)
ng/mL
group
vs.
118.85
43.07,
327.97)
group.
estimated
point
48.43
highest
sensitivity
(96%)
specificity
(97%)
analysis
both
yielded
similar
results.
Discussion
The
level
is
much
than
reported
It
may
be
used
tool
identify
among
range
concentrations
subjects
lower
acute
intrinsic
injury.
Systematic
Review
Registration
https://www.crd.york.ac.uk/
,
PROSPERO
(CRD42023370451).
International Journal of Women s Health,
Journal Year:
2024,
Volume and Issue:
Volume 16, P. 1595 - 1605
Published: Sept. 1, 2024
This
article
aims
to
bring
clinicians'
awareness
the
widespread
impact
of
urinary
tract
infection
(UTI)
on
lives
women
and
advances
that
offer
hope
for
future
improvements
in
diagnosis
management
UTI.
Thanks
physiological,
anatomical,
lifestyle
factor
differences,
face
heightened
vulnerability
UTIs
compared
men.
In
fact,
are
four
times
more
likely
than
men
develop
a
UTI
around
half
these
encounter
recurrence,
which
is
significant
source
both
physical
psychosocial
burdens.
Despite
current
shortcomings
management,
emerging
diagnostic
technologies
promise
identify
accurately
rapidly,
offering
revolution
management.
Meanwhile,
clinicians
have
opportunity
reduce
burden
by
recognizing
value
patients'
lived
experiences
ensuring
their
care
plan
alignment
with
goals
expectations
medical
care.
Clinical Microbiology Reviews,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 6, 2024
SUMMARY
Urinary
tract
infection
(UTI)
is
among
the
most
common
infections
in
clinical
practice.
In
some
cases,
if
left
untreated,
it
can
lead
to
pyelonephritis
and
urosepsis.
other
UTI
resolves
without
treatment.
Clinical
diagnosis
typically
based
on
patient
symptoms
and/or
urinalysis,
including
urine
dipsticks.
The
standard
culture
method
sometimes
employed
identify
suspected
urinary
pathogen
(uropathogen)
guide
antimicrobial
choice,
but
results
are
rarely
available
before
24
h.
also
misses
fastidious,
anaerobic,
slow-growing
uropathogens
reports
polymicrobial
infections.
unexplained
combination
of
negative
cultures
with
persistent
distressing
both
patients
clinicians.
Given
broad
appreciation
advantages
provided
by
rapid
testing
(e.g.,
for
COVID-19
or
influenza
A),
a
rapid,
accurate
diagnostic
test
needed
deliver
timely
treatment
seeking
care
that
optimizes
antibiotic
stewardship.
Herein,
we
discuss
progress
being
made
toward
an
accessible,
(i.e.,
within
hours),
assay
clinically
useful
treating
clinician
timeframe
growth
rate
pathogen(s)).
New
emerging
often
overlooked
current
techniques
reviewed.
Antibiotics,
Journal Year:
2024,
Volume and Issue:
13(12), P. 1214 - 1214
Published: Dec. 14, 2024
Background/Objectives:
While
new
methods
for
measuring
antimicrobial
susceptibility
have
been
associated
with
improved
patient
outcomes,
they
should
also
be
validated
using
standard
protocols
error
rates
and
other
test
metrics.
The
objective
of
this
study
was
to
validate
a
novel
assay
complicated
recurrent
urinary
tract
infections
(UTIs):
pooled
antibiotic
testing
(P-AST).
This
compared
broth
microdilution
(BMD)
disk
diffusion
(DD),
following
Clinical
Laboratory
Standards
Institute
(CLSI)
guidelines
assessment
agreement.
Methods:
analyzed
consecutive
fresh
clinical
urine
specimens
submitted
UTI
diagnostic
testing.
Upon
receipt,
the
samples
were
subjected
in
parallel
culture
multiplex
polymerase
chain
reaction
(M-PCR)
microbial
identification
quantification.
Specimens
same
monomicrobial
non-fastidious
bacteria
detected
by
both
M-PCR
(SUC)
underwent
(AST)
P-AST
Analysis
undertaken
assess
presence
heteroresistance
P-AST-resistant
BMD/DD
consensus-susceptible
results.
Results:
performance
measures
without
correction
showed
essential
agreement
(EA%)
≥90%,
very
major
errors
(VMEs)
<1.5%,
(MEs)
<3.0%
P-AST,
all
meeting
threshold
established
CLSI
AST.
categorical
(CA%)
met
acceptable
criteria
(>88%),
as
majority
minor
(mEs)
decreased
<1.0%
when
accounted
for.
Conclusions:
methodology
is
within
parameters
criteria.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(11), P. 2582 - 2582
Published: Nov. 12, 2024
Urinary
tract
infections
(UTIs)
are
common
bacterial
in
children.
UTIs
may
be
limited
to
the
bladder
or
involve
kidneys
with
possible
irreversible
damage.
Congenital
abnormalities
of
kidney
and
urinary
(CAKUT)
often
associated
UTIs;
scars
have
been
considered
a
consequence
untreated
but
congenital.
The
mechanism
by
which
bacteria
produce
inflammation
system
has
intensively
investigated.
Diagnostic
tools,
including
invasive
imaging
procedures,
advocated
infants
small
children
not
necessary
most
cases.
Effective
antibiotic
drugs
available,
prophylactic
treatment
questioned.
Several
guidelines
on
simple
one
for
general
practitioners
is
needed.
Diagnostic Microbiology and Infectious Disease,
Journal Year:
2024,
Volume and Issue:
111(3), P. 116646 - 116646
Published: Dec. 7, 2024
Complicated
urinary
tract
infections
(cUTIs)
are
difficult
to
manage
due
their
polymicrobial
nature
and
resistance
standard
therapies.
In
current
clinical
practice,
the
management
of
a
cUTI
often
starts
with
broad-spectrum
antimicrobials
until
culture
sensitivity
(C&S)
results
available,
but
these
diagnostic
delays
further
hinder
treatment
efficacy.
Polymerase
Chain
Reaction
(PCR)
offers
faster
alternative.
This
study
evaluates
PCR's
utility
compared
C&S,
focusing
on
agreeability,
discordant
results,
outcomes,
antimicrobial
selection
efficacy
improve
management.